Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

Analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ CALA opened at $0.02 on Wednesday. The firm has a fifty day moving average of $0.02 and a 200 day moving average of $0.03. Calithera Biosciences has a one year low of $0.02 and a one year high of $0.50.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.